These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 35844554)
1. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Czaja AJ Front Immunol; 2022; 13():921765. PubMed ID: 35844554 [TBL] [Abstract][Full Text] [Related]
2. Missing Causality and Heritability of Autoimmune Hepatitis. Czaja AJ Dig Dis Sci; 2023 Apr; 68(4):1585-1604. PubMed ID: 36261672 [TBL] [Abstract][Full Text] [Related]
3. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Czaja AJ Expert Rev Clin Immunol; 2022 Jun; 18(6):591-607. PubMed ID: 35510750 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes and their implications in autoimmune hepatitis. Czaja AJ Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29383703 [TBL] [Abstract][Full Text] [Related]
5. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. Czaja AJ World J Gastroenterol; 2019 Dec; 25(45):6579-6606. PubMed ID: 31832000 [TBL] [Abstract][Full Text] [Related]
6. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis. Czaja AJ; Montano-Loza AJ Dig Dis Sci; 2019 Feb; 64(2):324-344. PubMed ID: 30370494 [TBL] [Abstract][Full Text] [Related]
8. Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Czaja AJ Aliment Pharmacol Ther; 2014 Feb; 39(4):385-406. PubMed ID: 24387318 [TBL] [Abstract][Full Text] [Related]
9. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Czaja AJ Dig Dis Sci; 2018 Jul; 63(7):1706-1725. PubMed ID: 29671161 [TBL] [Abstract][Full Text] [Related]
10. microRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation. Tu H; Chen D; Cai C; Du Q; Lin H; Pan T; Sheng L; Xu Y; Teng T; Tu J; Lin Z; Wang X; Wang R; Xu L; Chen Y J Cell Mol Med; 2020 Jan; 24(2):1256-1267. PubMed ID: 31808606 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases. Shu Y; Hu Q; Long H; Chang C; Lu Q; Xiao R Clin Rev Allergy Immunol; 2017 Apr; 52(2):260-272. PubMed ID: 27687891 [TBL] [Abstract][Full Text] [Related]
12. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828 [TBL] [Abstract][Full Text] [Related]
13. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. Hartl J; Denzer U; Ehlken H; Zenouzi R; Peiseler M; Sebode M; Hübener S; Pannicke N; Weiler-Normann C; Quaas A; Lohse AW; Schramm C J Hepatol; 2016 Oct; 65(4):769-775. PubMed ID: 27238753 [TBL] [Abstract][Full Text] [Related]
14. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human. Musaddaq G; Shahzad N; Ashraf MA; Arshad MI Biomarkers; 2019 Mar; 24(2):103-109. PubMed ID: 30252499 [TBL] [Abstract][Full Text] [Related]
15. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis. Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis. Migita K; Komori A; Kozuru H; Jiuchi Y; Nakamura M; Yasunami M; Furukawa H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Kamitsukasa H; Nakamura Y; Ohta H; Shimada M; Takahashi H; Mita E; Hijioka T; Yamashita H; Kouno H; Nakamuta M; Ario K; Muro T; Sakai H; Sugi K; Nishimura H; Yoshizawa K; Sato T; Naganuma A; Komatsu T; Oohara Y; Makita F; Tomizawa M; Yatsuhashi H PLoS One; 2015; 10(11):e0136908. PubMed ID: 26575387 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364 [TBL] [Abstract][Full Text] [Related]
18. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Van Keuren-Jensen KR; Malenica I; Courtright AL; Ghaffari LT; Starr AP; Metpally RP; Beecroft TA; Carlson EW; Kiefer JA; Pockros PJ; Rakela J Liver Int; 2016 Mar; 36(3):334-43. PubMed ID: 26189820 [TBL] [Abstract][Full Text] [Related]
19. [Genetic risk factors for hepatic fibrosis in chronic liver diseases]. Wasmuth HE; Lammert F; Matern S Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677 [TBL] [Abstract][Full Text] [Related]